Modern treatment of ankylosing spondylitis

被引:2
|
作者
Rehart, S.
Kerschbaumer, F.
Braun, J.
Sieper, J.
机构
[1] Akad Lehrkrankenhaus, Markus KH, Klin Orthopad & Unfallchirurg, D-60431 Frankfurt, Germany
[2] Klin Rotes Kreuz, Frankfurt, Germany
[3] St Josefkrankenhaus, Rheumazentrum Ruhrgebiet, Herne, Germany
[4] Univ Med Berlin, Charite, Med Klin 1, Berlin, Germany
来源
ORTHOPADE | 2007年 / 36卷 / 10期
关键词
spondylarthritis ankylopoetica; inflammatory back pain; TNF alpha inhibitor; spondylodesis; synovectomy;
D O I
10.1007/s00132-007-1154-8
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Bechterew's disease belongs to subgroup of spondyloarthritis. Even today there is still a delay of 5-10 years between the first occurrence of symptoms and the final diagnosis of ankylosing spondylitis. Without treatment the spine increasingly stiffens and the peripheral (mostly large) joints are often destroyed by inflammatory processes. Ankyloses of the joints between vertebrae and ribs may cause stiffness of the thorax. As the complaints most often start within the third decade of life and show a chronic progressive course, even young adults often have to deal with a considerable impairment due to pain and stiffness. Thus, early diagnosis is of utmost importance as today treatment with novel drugs is feasible and the TNFα inhibitors are particularly effective during the early stages of the disease. All conservative orthopedic measures are used concomitantly. Surgery encompasses the early resection of inflamed mucosa in joints. In later stages of the disease reconstructive methods, i.e. prosthetics are often applied. Spondylodesis to erect the body, necessary in the end stage of the disease, is beneficial, but elaborate. © 2007 Springer Medizin Verlag.
引用
收藏
页码:963 / 972
页数:10
相关论文
共 50 条
  • [31] Infliximab in the treatment of ankylosing spondylitis
    Grainger, Rebecca
    Harrison, Andrew A.
    BIOLOGICS-TARGETS & THERAPY, 2007, 1 (02): : 163 - 171
  • [32] Outcomes in ankylosing spondylitis: what makes the assessment of treatment effects in ankylosing spondylitis different?
    Ward, M. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 25 - 28
  • [33] Treatment of rheumatoid arthritis and ankylosing spondylitis
    Braun, J.
    Sieper, J.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2009, 27 (04) : S146 - S147
  • [34] Rehabilitation Treatment Strategies in Ankylosing Spondylitis
    Calina, Matteo
    Ciancio, Giovanni
    Govoni, Marcello
    JOURNAL OF RHEUMATOLOGY, 2011, 38 (10) : 2266 - 2266
  • [35] STATIN TREATMENT IN PATIENTS WITH ANKYLOSING SPONDYLITIS
    Wibetoe, G.
    Ikdahl, E.
    Kvien, T. K.
    Rollefstad, S.
    Semb, A. G.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 812 - 812
  • [36] THE IMPORTANCE OF RADIOTHERAPY IN THE TREATMENT OF ANKYLOSING SPONDYLITIS
    RICHMOND, JJ
    PROCEEDINGS OF THE ROYAL SOCIETY OF MEDICINE-LONDON, 1951, 44 (06): : 445 - 447
  • [37] TREATMENT OF ANKYLOSING SPONDYLITIS (AS) DURING PREGNANCY
    Krichevskaya, O.
    Dubinina, T.
    Ilinykh, E.
    Glukhova, S.
    Demina, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1264 - 1264
  • [38] Adherence to treatment in patients with ankylosing spondylitis
    Arturi, Pablo
    Edith Schneeberger, Emilce
    Sommerfleck, Fernando
    Buschiazzo, Emilio
    Ledesma, Cesar
    Maldonado Cocco, Jose Antonio
    Citera, Gustavo
    CLINICAL RHEUMATOLOGY, 2013, 32 (07) : 1007 - 1015
  • [39] Operative Treatment of the Joints in Ankylosing Spondylitis
    Biehl, C.
    Kappl, S.
    Rehart, S.
    AKTUELLE RHEUMATOLOGIE, 2013, 38 (02) : 104 - 108
  • [40] Treatment of ankylosing spondylitis and other spondyloarthritides
    Braun, Juergen
    Baraliakos, Xenofon
    CURRENT OPINION IN RHEUMATOLOGY, 2009, 21 (04) : 324 - 334